
Meridian Bioscience VIVO
Quartalsbericht 2023-Q1
hinzugefügt 16.05.2026
Meridian Bioscience DSO 2011-2026 | VIVO
DSO Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.2 | 52.9 | 54.1 | 62.7 | 218 | 196 | 208 | 46.4 | 47.8 | 48.7 | 51.6 | 53.6 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 218 | 46.4 | 91.2 |
DSO Vierteljährlich Meridian Bioscience
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.7 | 69.3 | 70.1 | 42.5 | 45.8 | 44.7 | 62.6 | 45.9 | 40.2 | 40.9 | 44.4 | 60.1 | 68 | 64.8 | 61.2 | 58.9 | 56.4 | 53.8 | 55.2 | 58.1 | 52 | 52.2 | 50.2 | 46.6 | 40.9 | 54.2 | 61.9 | 54.1 | 53.8 | 53.8 | 56.5 | 51 | 45.7 | 47 | 51.4 | 47.6 | 42.8 | 48.6 | 45.6 | 46 | 48.5 | 48.4 | 54.6 | 56.4 | 48.3 | 54.7 | 54.5 | 52 | 43.9 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 70.1 | 40.2 | 52.5 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
63.8 | $ 115.08 | 0.1 % | $ 35 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 9.11 | 79.68 % | $ 12.1 M | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 19.69 | -2.28 % | $ 571 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
72.7 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
87 | $ 17.67 | 3.27 % | $ 544 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.54 | -0.42 % | $ 1.15 B | ||
|
Guardant Health
GH
|
46.1 | $ 119.85 | 0.76 % | $ 15 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.8 | -1.1 % | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 113.85 | -2.51 % | $ 9.39 B | ||
|
Illumina
ILMN
|
61.3 | $ 145.23 | 0.56 % | $ 23.1 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 100.06 | -2.85 % | $ 6.75 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 156.73 | -2.23 % | $ 7.77 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 101.33 | -0.16 % | $ 22.7 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 429.11 | -0.85 % | $ 12.4 B | ||
|
NeoGenomics
NEO
|
77.7 | $ 9.27 | 0.43 % | $ 1.19 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.04 | -0.21 % | $ 426 M | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
81.5 | $ 200.91 | -1.12 % | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 3.85 | 0.79 % | $ 357 M | ||
|
Personalis
PSNL
|
63.8 | $ 8.94 | 5.55 % | $ 798 M | ||
|
Senseonics Holdings
SENS
|
1.04 | $ 6.43 | 1.42 % | $ 268 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
27 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.47 | -0.8 % | $ 5.67 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 258.45 | -0.57 % | $ 21.5 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 64.87 | 7.1 % | $ 3.88 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 448.18 | -0.02 % | $ 169 B | ||
|
Waters Corporation
WAT
|
306 | $ 338.64 | -1.09 % | $ 20.2 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.65 | 7.49 % | $ 233 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.14 | 2.7 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 192.88 | -1.19 % | $ 21.4 B |